JOSE MILERA: Open Payments
NPI 1144689639 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 36 payments from 9 companies in 2025. Trend: 2023 $444 · 2024 $627 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $194 |
| Lilly USA, LLC | 14 | $142 |
| Amgen Inc. | 2 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: MOUNJARO, Wegovy, Ozempic, REPATHA, Kerendia, LEQVIO, Rybelsus, REXULTI.
Industry payments across TX — which companies pay providers there.
